» Articles » PMID: 17097062

AMP-activated Protein Kinase Regulates PEPCK Gene Expression by Direct Phosphorylation of a Novel Zinc Finger Transcription Factor

Overview
Publisher Elsevier
Specialty Biochemistry
Date 2006 Nov 14
PMID 17097062
Citations 21
Authors
Affiliations
Soon will be listed here.
Abstract

AMP-activated protein kinase (AMPK) acts as an intracellular sensor for maintaining the energy balance. Activation of AMPK switches on ATP-generating process while switches off ATP-consuming process. It achieves these effects by phosphorylation of downstream metabolic enzymes. It has been proposed that AMPK also regulates gene expression through phosphorylation of certain transcription factors; however its molecular mechanism is not fully understood. Here we show the cloning and characterization of a novel zinc finger transcription factor referred to as AREBP. AREBP is phosphorylated at Ser(470) by AMPK. Phosphorylation reduces the DNA-binding activity of AREBP. Transient transfection experiments indicate that wild-type AREBP, but not Ser(470) to Ala(470) substituted non-phosphorylating mutant, represses gene expression of the phosphoenolpyruvate carboxykinase (PEPCK), a key enzyme of gluconeogenesis. RNA interference-mediated reduction of endogenous AREBP expression attenuates AMPK-induced PEPCK down-regulation. These results implicate AREBP as a novel key modulator of PEPCK gene expression regulated by AMPK.

Citing Articles

The role of acetylation and deacetylation in cancer metabolism.

Wang C, Ma X Clin Transl Med. 2025; 15(1):e70145.

PMID: 39778006 PMC: 11706801. DOI: 10.1002/ctm2.70145.


and Its Constituent, Atractylodin, Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease via AMPK Activation.

Song G, Kim S, Back S, Yang S, Yang Y Biomol Ther (Seoul). 2024; 32(6):778-792.

PMID: 39391981 PMC: 11535289. DOI: 10.4062/biomolther.2024.083.


ZNF692 promotes the migration and response to immunotherapy of clear cell renal cell carcinoma cells by targeting metabolic pathway.

Liu Y, Zeng D, Gao Y Discov Oncol. 2024; 15(1):158.

PMID: 38735008 PMC: 11089031. DOI: 10.1007/s12672-024-01005-0.


ZNF692 drives malignant development of hepatocellular carcinoma cells by promoting ALDOA-dependent glycolysis.

Meng W, Lu X, Wang G, Xiao Q, Gao J Funct Integr Genomics. 2024; 24(2):53.

PMID: 38453820 PMC: 10920453. DOI: 10.1007/s10142-024-01326-x.


Comprehensive analysis of ZNF692 as a potential biomarker associated with immune infiltration in a pan cancer analysis and validation in hepatocellular carcinoma.

Cai H, Chen S, Wu Z, Wang F, Tang S, Li D Aging (Albany NY). 2023; 15(22):13041-13058.

PMID: 37980166 PMC: 10713400. DOI: 10.18632/aging.205218.